DUBLIN–(BUSINESS WIRE)–The “Neurological Disorder Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027” report has been added to ResearchAndMarkets.com’s offering.
This report studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2019 to 2027.
The report provides the revenue of the global neurological disorder drugs market for the period 2017-2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global neurological disorder drugs market from 2019 to 2027.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global neurological disorder drugs market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global neurological disorder drugs market.
The report also delves into the competitive landscape of the global neurological disorder drugs market. Key players operating in the global neurological disorder drugs market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global neurological disorder drugs market that have been profiled in this report.
Key Questions Answered
- What is the sales/revenue generated by neurological disorder drugs across all regions during the forecast period?
- What are the opportunities in the global neurological disorder drugs market?
- What are the major drivers, restraints, opportunities, and threats in the global market?
- Which region is set to expand at the fastest CAGR during the forecast period?
- Which disorder segment is expected to generate the highest revenue globally in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Key Topics Covered
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Neurological Disorder Drugs Market
4. Market Overview
4.1. Introduction & Overview
4.2. Product Overview
4.3. Market Dynamics
4.4. Global Neurological Disorder Drugs Market Analysis and Forecast, 2017-2027
5. Market Outlook
5.1. Pipeline Analysis
5.2. Disease Prevalence & Incidence Rate globally with key countries
5.3. Regulatory Scenario
6. Global Neurological Disorder Drugs Market Analysis and Forecast, by Disorder
6.1. Introduction & Definition
6.2. Global Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Disorder, 2017-2027
6.3. Global Neurological Disorder Drugs Market Attractiveness Analysis, by Disorder
7. Global Neurological Disorder Drugs Market Analysis and Forecast, by Drug Class
7.1. Introduction & Definition
7.2. Global Neurological Disorder Drugs Market Value (US$) Forecast, by Drug Class, 2017-2027
7.3. Global Neurological Disorder Drugs Market Attractiveness Analysis, by Drug Class
8. Global Neurological Disorder Drugs Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Global Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
8.3. Global Neurological Disorder Drugs Market Attractiveness Analysis, by Distribution Channel
9. Global Neurological Disorder Drugs Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Region
9.3. Global Neurological Disorder Drugs Market Attractiveness Analysis, by Region
10. North America Neurological Disorder Drugs Market Analysis and Forecast
11. Europe Neurological Disorder Drugs Market Analysis and Forecast
12. Asia-Pacific Neurological Disorder Drugs Market Analysis and Forecast
13. Latin America Neurological Disorder Drugs Market Analysis and Forecast
14. Middle East & Africa Neurological Disorder Drugs Market Analysis and Forecast
15. Competition Landscape
15.1. Competition Matrix
15.2. Market Share Analysis, by Company, 2018
15.3. Company Profiles
- Novartis AG
- GlaxoSmithKline plc
- F. Hoffmann-La Roche Ltd
- Pfizer, Inc.
- Bayer AG
- Boehringer Ingelheim International GmbH
- AstraZeneca plc
- Teva Pharmaceutical Industries Ltd.
- Merck & Co. Inc.
- Otsuka Pharmaceutical Co. Ltd.
- Amgen, Inc
- UCB S.A.
- Eli Lilly and Company
- Biogen
For more information about this report visit https://www.researchandmarkets.com/r/eu1gtq.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900